Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-009-0349-6.pdf
Reference26 articles.
1. Borresen AL (1992) Role of genetic factors in breast cancer susceptibility. Acta Oncol 31:151–155. doi: 10.3109/02841869209088896
2. Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103–105. doi: 10.1016/j.ccr.2007.01.010
3. Manoukian S, Peissel B, Pensotti V et al (2007) Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families. Eur J Cancer 43:601–606. doi: 10.1016/j.ejca.2006.09.024
4. May P, May E (1999) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18:7621–7636. doi: 10.1038/sj.onc.1203285
5. Li WF, Hu Z, Rao NY et al (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110:99–109. doi: 10.1007/s10549-007-9708-3
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients;Journal of Genetics and Genomics;2022-07
2. Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients;BMC Cancer;2020-11-02
3. Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing;Chinese Journal of Cancer Research;2020
4. Li–Fraumeni syndrome heterogeneity;Clinical and Translational Oncology;2019-11-05
5. Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China;International Journal of Cancer;2019-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3